Insurer Centene to buy Magellan in $2.2 billion mental health push

By Manas Mishra, Dania Nadeem and Rebecca Spalding (Reuters) -Health insurer Centene Corp said on Monday it has agreed to buy Magellan Health Inc in a $2.2 billion deal including debt, looking to build up its mental health services as more Americans struggle with COVID-19-related behavioral and anxiety issues. Centene has offered $95 per share in cash, a 14.7% premium to the pharmacy benefits manager's Thursday closing price.

Reuters January 05, 2021 02:05:41 IST
Insurer Centene to buy Magellan in $2.2 billion mental health push

Insurer Centene to buy Magellan in 22 billion mental health push

By Manas Mishra, Dania Nadeem and Rebecca Spalding

(Reuters) -Health insurer Centene Corp said on Monday it has agreed to buy Magellan Health Inc in a $2.2 billion deal including debt, looking to build up its mental health services as more Americans struggle with COVID-19 -related behavioral and anxiety issues.

Centene has offered $95 per share in cash, a 14.7% premium to the pharmacy benefits manager's Thursday closing price.

Shares of Magellan Health, which also provides mental health services to patients with serious mental illness, autism and opioid and substance use, were up 13.1% at $93.70 on Monday afternoon on the Nasdaq.

The move by Centene to expand mental health support comes as more than two out of five Americans are struggling with mental or behavioral health issues associated with the pandemic, the company said.

"I was thinking about it long before the pandemic, the pandemic just emphasized it," said Centene Chairman, President and Chief Executive Michael Neidorff.

Magellan's divestiture of a business unit earlier this year that was similar to Centene's was the catalyst that allowed a deal to move forward, Neidorff said.

Centene's patients, after being diagnosed with a serious illness, such as cancer, would benefit from having increased access to mental health care, Neidorff added.

The deal will add 2 million pharmacy benefit members and 16 million medical pharmacy members to Centene's portfolio, the company said.

It would also bring to Centene 18 million third-party customers of specialty health services, which includes physical medicine and rehabilitation to people with disabilities.

There has been a wave of healthcare industry consolidation in recent years between insurers and pharmacy benefit managers, driven by pressure from governments and large corporations to lower soaring medical costs.

Large deals include CVS Health Corp's $69 billion acquisition of health insurer Aetna Inc and Cigna Corp's $52 billion deal to buy PBM Express Scripts Holding Co.

Centene and Magellan Health expect to complete the transaction in the second half of 2021.

(Reporting by Manas Mishra and Dania Nadeem in Bengaluru and Rebecca Spalding in New YorkEditing by Arun Koyyur and Matthew Lewis)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Trump disavows any responsibility for his supporters' Jan. 6 attack
World

Trump disavows any responsibility for his supporters' Jan. 6 attack

By Steve Holland and Andrea Shalal JOINT BASE ANDREWS, Md./WASHINGTON (Reuters) - U.S. President Donald Trump, facing impeachment on a charge of "incitement of insurrection" on Tuesday disavowed responsibility for his supporters' violent invasion of the U.S. Capitol last week and said his remarks before the siege were appropriate.

Renault and Plug Power to develop fuel-cell commerical vehicles
News & Analysis

Renault and Plug Power to develop fuel-cell commerical vehicles

PARIS (Reuters) - French carmaker Renault and U.S. hydrogen specialist Plug Power have joined forces to develop hydrogen-powered light commercial vehicles, they said on Tuesday. The companies have signed a memorandum of understanding to launch a France-based 50-50 joint venture by the end of the first half of 2021, targeting more than 30% share of the fuel cell-powered light commercial vehicle market in Europe, their joint statement said

Analysis: Tesla's Model Y to emerge disruptor as China EV sales zoom in 2021
News & Analysis

Analysis: Tesla's Model Y to emerge disruptor as China EV sales zoom in 2021

By Yilei Sun and Brenda Goh BEIJING/SHANGHAI (Reuters) - New models will help electric vehicle sales in China zoom this year, after tepid business in a virus-riddled 2020, and analysts predict Tesla's Model Y pricing will emerge as a major disruptor in the world's biggest car market. Tesla Inc, which became the world's most valuable car maker last year, started selling locally made Model Y SUVs in China this month, for almost a tenth less than gasoline-powered luxury cars with similar market positioning. It set the starting price at 339,900 yuan ($52,376), or 10% below official prices of Daimler's Mercedes GLC, BMW's X3 and Audi's Q5L - all locally made gasoline sport utility vehicles (SUVs) with similar size and positioning.